nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Febrile neutropenia—Carmustine—malignant glioma	0.0299	0.0299	CcSEcCtD
Degarelix—Transaminases increased—Carmustine—malignant glioma	0.0295	0.0295	CcSEcCtD
Degarelix—Febrile neutropenia—Temozolomide—malignant glioma	0.0289	0.0289	CcSEcCtD
Degarelix—Abscess—Carmustine—malignant glioma	0.0227	0.0227	CcSEcCtD
Degarelix—Breast pain—Temozolomide—malignant glioma	0.0199	0.0199	CcSEcCtD
Degarelix—Injection site reaction—Carmustine—malignant glioma	0.0179	0.0179	CcSEcCtD
Degarelix—Musculoskeletal pain—Temozolomide—malignant glioma	0.0176	0.0176	CcSEcCtD
Degarelix—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.0174	0.0174	CcSEcCtD
Degarelix—Influenza like illness—Temozolomide—malignant glioma	0.0169	0.0169	CcSEcCtD
Degarelix—Gynaecomastia—Carmustine—malignant glioma	0.0161	0.0161	CcSEcCtD
Degarelix—Mental disability—Carmustine—malignant glioma	0.0156	0.0156	CcSEcCtD
Degarelix—Mental disability—Temozolomide—malignant glioma	0.0151	0.0151	CcSEcCtD
Degarelix—Diabetes mellitus—Carmustine—malignant glioma	0.015	0.015	CcSEcCtD
Degarelix—Swelling—Carmustine—malignant glioma	0.0148	0.0148	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0145	0.0145	CcSEcCtD
Degarelix—Hot flush—Temozolomide—malignant glioma	0.0135	0.0135	CcSEcCtD
Degarelix—Menopausal symptoms—Temozolomide—malignant glioma	0.0134	0.0134	CcSEcCtD
Degarelix—Muscular weakness—Carmustine—malignant glioma	0.0115	0.0115	CcSEcCtD
Degarelix—Breast disorder—Temozolomide—malignant glioma	0.0114	0.0114	CcSEcCtD
Degarelix—Muscular weakness—Temozolomide—malignant glioma	0.0111	0.0111	CcSEcCtD
Degarelix—Dysuria—Temozolomide—malignant glioma	0.0102	0.0102	CcSEcCtD
Degarelix—Hyperglycaemia—Carmustine—malignant glioma	0.0102	0.0102	CcSEcCtD
Degarelix—Pollakiuria—Temozolomide—malignant glioma	0.0101	0.0101	CcSEcCtD
Degarelix—Erectile dysfunction—Temozolomide—malignant glioma	0.01	0.01	CcSEcCtD
Degarelix—Depression—Carmustine—malignant glioma	0.01	0.01	CcSEcCtD
Degarelix—Weight increased—Temozolomide—malignant glioma	0.00991	0.00991	CcSEcCtD
Degarelix—Renal failure—Carmustine—malignant glioma	0.00988	0.00988	CcSEcCtD
Degarelix—Weight decreased—Temozolomide—malignant glioma	0.00986	0.00986	CcSEcCtD
Degarelix—Hyperglycaemia—Temozolomide—malignant glioma	0.00983	0.00983	CcSEcCtD
Degarelix—Urinary tract infection—Carmustine—malignant glioma	0.00977	0.00977	CcSEcCtD
Degarelix—Depression—Temozolomide—malignant glioma	0.00969	0.00969	CcSEcCtD
Degarelix—Urinary tract infection—Temozolomide—malignant glioma	0.00944	0.00944	CcSEcCtD
Degarelix—Hepatobiliary disease—Temozolomide—malignant glioma	0.00919	0.00919	CcSEcCtD
Degarelix—Hypoaesthesia—Carmustine—malignant glioma	0.00898	0.00898	CcSEcCtD
Degarelix—Oedema peripheral—Carmustine—malignant glioma	0.00889	0.00889	CcSEcCtD
Degarelix—Hypoaesthesia—Temozolomide—malignant glioma	0.00868	0.00868	CcSEcCtD
Degarelix—Urinary tract disorder—Temozolomide—malignant glioma	0.00861	0.00861	CcSEcCtD
Degarelix—Oedema peripheral—Temozolomide—malignant glioma	0.00859	0.00859	CcSEcCtD
Degarelix—Urethral disorder—Temozolomide—malignant glioma	0.00855	0.00855	CcSEcCtD
Degarelix—Eye disorder—Carmustine—malignant glioma	0.00843	0.00843	CcSEcCtD
Degarelix—Eye disorder—Temozolomide—malignant glioma	0.00815	0.00815	CcSEcCtD
Degarelix—Cardiac disorder—Temozolomide—malignant glioma	0.00809	0.00809	CcSEcCtD
Degarelix—Arrhythmia—Carmustine—malignant glioma	0.00806	0.00806	CcSEcCtD
Degarelix—Alopecia—Carmustine—malignant glioma	0.00797	0.00797	CcSEcCtD
Degarelix—Angiopathy—Temozolomide—malignant glioma	0.00791	0.00791	CcSEcCtD
Degarelix—Mental disorder—Carmustine—malignant glioma	0.00791	0.00791	CcSEcCtD
Degarelix—Immune system disorder—Temozolomide—malignant glioma	0.00788	0.00788	CcSEcCtD
Degarelix—Mediastinal disorder—Temozolomide—malignant glioma	0.00786	0.00786	CcSEcCtD
Degarelix—Malnutrition—Carmustine—malignant glioma	0.00786	0.00786	CcSEcCtD
Degarelix—Erythema—Carmustine—malignant glioma	0.00786	0.00786	CcSEcCtD
Degarelix—Chills—Temozolomide—malignant glioma	0.00782	0.00782	CcSEcCtD
Degarelix—Alopecia—Temozolomide—malignant glioma	0.00771	0.00771	CcSEcCtD
Degarelix—Mental disorder—Temozolomide—malignant glioma	0.00764	0.00764	CcSEcCtD
Degarelix—Back pain—Carmustine—malignant glioma	0.0076	0.0076	CcSEcCtD
Degarelix—Malnutrition—Temozolomide—malignant glioma	0.00759	0.00759	CcSEcCtD
Degarelix—Erythema—Temozolomide—malignant glioma	0.00759	0.00759	CcSEcCtD
Degarelix—Vision blurred—Carmustine—malignant glioma	0.0074	0.0074	CcSEcCtD
Degarelix—Back pain—Temozolomide—malignant glioma	0.00734	0.00734	CcSEcCtD
Degarelix—Anaemia—Carmustine—malignant glioma	0.00726	0.00726	CcSEcCtD
Degarelix—Vision blurred—Temozolomide—malignant glioma	0.00715	0.00715	CcSEcCtD
Degarelix—Ill-defined disorder—Temozolomide—malignant glioma	0.00704	0.00704	CcSEcCtD
Degarelix—Anaemia—Temozolomide—malignant glioma	0.00702	0.00702	CcSEcCtD
Degarelix—Malaise—Temozolomide—malignant glioma	0.00685	0.00685	CcSEcCtD
Degarelix—Hypertension—Carmustine—malignant glioma	0.00678	0.00678	CcSEcCtD
Degarelix—Palpitations—Temozolomide—malignant glioma	0.00671	0.00671	CcSEcCtD
Degarelix—Hypertension—Temozolomide—malignant glioma	0.00655	0.00655	CcSEcCtD
Degarelix—Arthralgia—Temozolomide—malignant glioma	0.00646	0.00646	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00642	0.00642	CcSEcCtD
Degarelix—Discomfort—Temozolomide—malignant glioma	0.00639	0.00639	CcSEcCtD
Degarelix—Dry mouth—Temozolomide—malignant glioma	0.00632	0.00632	CcSEcCtD
Degarelix—Anaphylactic shock—Temozolomide—malignant glioma	0.0062	0.0062	CcSEcCtD
Degarelix—Nervous system disorder—Temozolomide—malignant glioma	0.00608	0.00608	CcSEcCtD
Degarelix—Skin disorder—Temozolomide—malignant glioma	0.00602	0.00602	CcSEcCtD
Degarelix—Hypotension—Carmustine—malignant glioma	0.00599	0.00599	CcSEcCtD
Degarelix—Hyperhidrosis—Temozolomide—malignant glioma	0.00599	0.00599	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00584	0.00584	CcSEcCtD
Degarelix—Insomnia—Carmustine—malignant glioma	0.0058	0.0058	CcSEcCtD
Degarelix—Dyspnoea—Carmustine—malignant glioma	0.00572	0.00572	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00564	0.00564	CcSEcCtD
Degarelix—Insomnia—Temozolomide—malignant glioma	0.0056	0.0056	CcSEcCtD
Degarelix—Decreased appetite—Carmustine—malignant glioma	0.00557	0.00557	CcSEcCtD
Degarelix—Gastrointestinal disorder—Carmustine—malignant glioma	0.00553	0.00553	CcSEcCtD
Degarelix—Dyspnoea—Temozolomide—malignant glioma	0.00552	0.00552	CcSEcCtD
Degarelix—Pain—Carmustine—malignant glioma	0.00548	0.00548	CcSEcCtD
Degarelix—Constipation—Carmustine—malignant glioma	0.00548	0.00548	CcSEcCtD
Degarelix—Decreased appetite—Temozolomide—malignant glioma	0.00539	0.00539	CcSEcCtD
Degarelix—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00535	0.00535	CcSEcCtD
Degarelix—Fatigue—Temozolomide—malignant glioma	0.00534	0.00534	CcSEcCtD
Degarelix—Pain—Temozolomide—malignant glioma	0.0053	0.0053	CcSEcCtD
Degarelix—Constipation—Temozolomide—malignant glioma	0.0053	0.0053	CcSEcCtD
Degarelix—Feeling abnormal—Carmustine—malignant glioma	0.00528	0.00528	CcSEcCtD
Degarelix—Gastrointestinal pain—Carmustine—malignant glioma	0.00524	0.00524	CcSEcCtD
Degarelix—Feeling abnormal—Temozolomide—malignant glioma	0.00511	0.00511	CcSEcCtD
Degarelix—Abdominal pain—Carmustine—malignant glioma	0.00507	0.00507	CcSEcCtD
Degarelix—Body temperature increased—Carmustine—malignant glioma	0.00507	0.00507	CcSEcCtD
Degarelix—Gastrointestinal pain—Temozolomide—malignant glioma	0.00507	0.00507	CcSEcCtD
Degarelix—Urticaria—Temozolomide—malignant glioma	0.00492	0.00492	CcSEcCtD
Degarelix—Abdominal pain—Temozolomide—malignant glioma	0.0049	0.0049	CcSEcCtD
Degarelix—Body temperature increased—Temozolomide—malignant glioma	0.0049	0.0049	CcSEcCtD
Degarelix—Hypersensitivity—Carmustine—malignant glioma	0.00472	0.00472	CcSEcCtD
Degarelix—Asthenia—Carmustine—malignant glioma	0.0046	0.0046	CcSEcCtD
Degarelix—Hypersensitivity—Temozolomide—malignant glioma	0.00456	0.00456	CcSEcCtD
Degarelix—Asthenia—Temozolomide—malignant glioma	0.00445	0.00445	CcSEcCtD
Degarelix—Diarrhoea—Carmustine—malignant glioma	0.00439	0.00439	CcSEcCtD
Degarelix—Pruritus—Temozolomide—malignant glioma	0.00438	0.00438	CcSEcCtD
Degarelix—Dizziness—Carmustine—malignant glioma	0.00424	0.00424	CcSEcCtD
Degarelix—Diarrhoea—Temozolomide—malignant glioma	0.00424	0.00424	CcSEcCtD
Degarelix—Dizziness—Temozolomide—malignant glioma	0.0041	0.0041	CcSEcCtD
Degarelix—Vomiting—Carmustine—malignant glioma	0.00408	0.00408	CcSEcCtD
Degarelix—Rash—Carmustine—malignant glioma	0.00404	0.00404	CcSEcCtD
Degarelix—Dermatitis—Carmustine—malignant glioma	0.00404	0.00404	CcSEcCtD
Degarelix—Headache—Carmustine—malignant glioma	0.00402	0.00402	CcSEcCtD
Degarelix—Vomiting—Temozolomide—malignant glioma	0.00394	0.00394	CcSEcCtD
Degarelix—Rash—Temozolomide—malignant glioma	0.00391	0.00391	CcSEcCtD
Degarelix—Dermatitis—Temozolomide—malignant glioma	0.0039	0.0039	CcSEcCtD
Degarelix—Headache—Temozolomide—malignant glioma	0.00388	0.00388	CcSEcCtD
Degarelix—Nausea—Carmustine—malignant glioma	0.00381	0.00381	CcSEcCtD
Degarelix—Nausea—Temozolomide—malignant glioma	0.00368	0.00368	CcSEcCtD
